Table 3.

Breakdown of objective responses to different chemotherapeutic regimens used in the post-PARPi setting according to pre-PARPi platinum sensitivity

Response by RECIST and/or GCIG criteria (events/evaluable; %)
Chemotherapeutic regimen usedPlatinum-resistantPlatinum-partially sensitivePlatinum-sensitive
Platinum-based chemotherapies5/14 (36)16/26 (62)5/13 (38)
 Platinum single-agent1/3 (33)1/2 (50)1/1 (100)
 Platinum-taxane3/5 (60)9/10 (90)2/7 (29)
 Platinum-PLD1/4 (25)3/5 (60)1/2 (50)
 Platinum-others0/2 (0)3/9 (33)1/3 (33)
Taxane single-agent3/8 (38)2/2 (100)0/0 (0)
PLD single-agent2/6 (33)1/3 (33)0/1 (0)
Others1/2 (50)0/3 (0)0/0 (0)
Total11/30 (37)19/34 (56)5/14 (36)